Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders
US-2024199583-A1 · Jun 20, 2024 · US
US9890131B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9890131-B2 |
| Application number | US-201415102298-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 19, 2014 |
| Priority date | Dec 20, 2013 |
| Publication date | Feb 13, 2018 |
| Grant date | Feb 13, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method of preparing a glycol mono-ether or mono-acetate, or carbonate involving either one of two pathways from alkylene glycols, HMF or its reduction derivative products (i.e., FDM, bHMTHFs), is provided. In particular, according to one pathway, the alkylene glycol, HMF or FDM, bHMTHFs are reacted with a dialkyl carbonate in the presence of a deprotonating agent, in substantial absence of an extrinsic catalyst, to produce an ether, and subsequently reacting the ether with an acid base. According to the other pathway, alkylene glycols are reacted with an acetate donor in the presence of an acid, base, to generate an alkylene mono-acetate, and etherified with a carbonate in the presence of a deprotonating agent.
Opening claim text (preview).
We claim: 1. A method of preparing a mono-ester-ether from a linear or mono-cyclic diol compound, comprising either a first pathway or second pathway, wherein: in the first pathway, a diol compound selected from the group consisting of ethylene glycol (EG), propylene glycol (PG), 2,3 butane diol (BDO), furandimethanol and tetrahydrofuran dimethanol is contacted with an R 1 organic acid of the formula R 1 —CO 2 H wherein R 1 is a C 1 to C 8 alkyl, cycloalkyl or aromatic moiety in the presence of a Brønsted acid at a temperature and for time sufficient to form a R 1 mono ester of the diol compound, then the R 1 mono ester of the diol compound is contacted with a R 2 alkyl diester of the formula R 2 (CO 3 )R 2 in which R 2 is a C 1 to C 8 alkyl moiety in the presence of a deprotonating agent at a temperature and for a time sufficient to form the monoester ether; or in the second pathway, a diol compound selected from the group consisting of ethylene glycol (EG), propylene glycol (PG), 2,3 butane diol (BDO), furandimethanol and tetrahydrofuran dimethanol is contacted with the an R 2 alkyl diester of the formula R 2 (CO 3 )R 2 in which R 2 is a C1 to C8 alkyl moiety in the presence of a deprotonating agent at a temperature and for a time sufficient to form a mono ether of the diol compound, then the mono ether of the diol compound is contacted with an R 1 organic acid of the formula R 1 —CO 2 H wherein R 1 is a C 1 to C 8 alkyl, cycloalkyl or aromatic moiety in the presence of a Brønsted acid at a temperature and for time sufficient to form the monoester ether. 2. The method according to claim 1 , wherein said R 1 organic acid is acetic acid and said mono-ester-ether is an ether acetate compound. 3. The method according to claim 1 , wherein said deprotonating agent is a Brønsted base. 4. The method according to claim 1 , wherein said deprotonating agent is selected from the group consisting of potassium carbonate, sodium carbonate, calcium carbonate, and an amine. 5. The method according to claim 1 , wherein said temperature for contacting with the Brønsted acid and with the deprotonating agent is at a temperature between about 70° C. and 150° C. 6. The method according to claim 1 , wherein said temperature for contacting with the Brønsted acid and with the deprotonating agent is at a temperature between about 80° C. and 130° C. 7. The method according to claim 1 wherein said temperature for contacting with the Brønsted acid and with the deprotonating agent is at a temperature between about 90° C. to about 120° C. 8. The method according to claim 1 , wherein said deprotonating agent is an inorganic carbonate present in an amount of at least one (1) to about three (3) stoichiometric equivalents per diol compound.
by increase in the number of carbon atoms · CPC title
Ortho-condensed systems · CPC title
Radicals substituted by oxygen atoms · CPC title
Singly bound oxygen atoms · CPC title
from organic carbonates · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.